GoodRx shared its first full-year earnings since becoming a publicly-traded company this week, boasting substantial revenue growth and increases in its membership.
The prescription price comparison platform was able to make these advancements despite pandemic-related care deferrals, skipped medication refills and an “unusually weak cold and flu season,'' according to the shareholder letter.
TOP-...
Despite the challenges of 2020, Dexcom was able to close the year out with financial growth for both the fourth quarter and the full year, according to its earnings report released Thursday.
In the earnings call, Dexcom’s chairman, president and CEO Kevin Sayer voiced his gratitude to the company for surpassing its goals even under the extreme circumstances last year.
“In any given year, these...
